Stryker
Worldwide Headquarters
2825 Airview Boulevard
Kalamazoo
Michigan
49002
United States
Tel: 269-385-2600
Fax: 269-385-1062
Website: http://www.stryker.com/
289 articles with Stryker
-
CD NXT power tool system empowers surgeons through real-time depth measurement
3/2/2023
Stryker announced the launch of its CD NXT System, the latest innovation in the company's power tools.
-
Stryker’s Q Guidance System for cranial applications receives FDA clearance
2/17/2023
Stryker, one of the world’s leading medical technology companies, announced that its Q Guidance System with Cranial Guidance Software received 510 clearance from the U.S. Food and Drug Administration.
-
Stryker reports 2022 operating results and 2023 outlook
1/31/2023
Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2022.
-
Stryker to host conference call on January 31, 2023
12/28/2022
Stryker announced that it will host a conference call on Tuesday, January 31, 2023 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ending December 31, 2022 and provide an operational update.
-
Stryker launches Citrefix™ Suture Anchor System, featuring award-winning Citregen biomaterial designed to support bone regeneration and the natural healing process
12/13/2022
Stryker (NYSE:SYK) today announced the launch of Citrefix™, a suture anchor system for foot and ankle surgical procedures.
-
Stryker declares a $0.75 per share quarterly dividend
12/7/2022
Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.75 per share payable January 31, 2023 to shareholders of record at the close of business on December 30, 2022, representing an increase of 7.9% versus the prior year and previous quarter.
-
Stryker opens the OR of the Future for customers to experience tomorrow's OR today
11/14/2022
Stryker, one of the world's leading medical technology companies, unveiled the OR of the Future—a model operating room inside Stryker's Flower Mound facility, providing a one-of-a-kind interactive experience for customers to conceptualize new OR design and technology.
-
Stryker to participate in the 5th Annual Evercore ISI HealthCONx Conference
11/3/2022
Stryker will participate in the 5th Annual Evercore ISI HealthCONx Conference on Thursday, December 1, 2022.
-
Stryker reports third quarter 2022 operating results
10/31/2022
Stryker (NYSE:SYK) reported operating results for the third quarter of 2022.
-
Stryker to Showcase Innovative Portfolio of Spine Solutions at the North American Spine Society Meeting
10/12/2022
Stryker, one of the world’s leading medical technology companies, will feature its suite of procedural solutions for spinal surgery, including its award-winning Q Guidance System with Spine Guidance Software, during the North American Spine Society annual meeting in Chicago, Oct. 12–15.
-
Stryker Launches Monterey AL Interbody System with New Pre-clinical Data
10/4/2022
Stryker announced the launch of the Monterey AL Interbody System, a stand-alone interbody fusion device designed for anterior lumbar interbody fusion.
-
Stryker to host conference call on October 31, 2022
9/29/2022
Stryker announced that it will host a conference call on Monday, October 31, 2022 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ending September 30, 2022 and provide an operational update.
-
Stryker Launches Q Guidance System with Spine Guidance Software
9/27/2022
Stryker (NYSE:SYK), one of the world’s leading medical technology companies, announced today the launch of its Q Guidance System for spine applications.
-
The U.S. FDA had a busy week with a range of drug approvals, advisory committee meetings and classification announcements.
-
Stryker receives FDA clearance for OptaBlate™ Bone Tumor Ablation System
9/20/2022
Stryker announced today that its OptaBlate bone tumor ablation system (OptaBlate) received 510(k) clearance from the U.S. Food and Drug Administration.
-
Stryker Launches Pulse Intelligent Delivery Platform at the 2022 American Orthopaedic Foot & Ankle Society Annual Meeting
9/14/2022
Stryker (NYSE:SYK) today announced the launch of its Pulse Intelligent Delivery Platform, a full-circle product and fulfillment offering optimized for high volume foot and ankle procedures in the ambulatory surgery center (ASC) setting, which will debut at the 2022 American Orthopaedic Foot & Ankle Society Annual Meeting (AOFAS).
-
Stryker Launches New Gamma4 Hip Fracture Nailing System
9/1/2022
Stryker has launched the Gamma4 System, strengthening the product’s 30-year legacy of continuous innovation and clinical history.
-
Stryker to participate in the 2022 Wells Fargo Securities Healthcare Conference
8/22/2022
Stryker (NYSE:SYK) will participate in the 2022 Wells Fargo Securities Healthcare Conference on Thursday, September 8, 2022.
-
BioSpace spoke with Jay Johnson, the Director of Talent Acquisition for Orthopedics at Stryker, to find out what it takes to land a job in medical sales.
-
Stryker reports second quarter 2022 operating results
7/26/2022
Stryker (NYSE:SYK) reported operating results for the second quarter of 2022.